Boston Scientific (NYSE:BSX) announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX ...
Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback